<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A patient with previously undiagnosed <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) developed atypical <z:e sem="disease" ids="C0341950,C0156669" disease_type="Disease or Syndrome" abbrv="">severe preeclampsia</z:e> at 31 weeks' gestation </plain></SENT>
<SENT sid="1" pm="."><plain>Other <z:e sem="disease" ids="C0032962" disease_type="Disease or Syndrome" abbrv="">complications of pregnancy</z:e> included <z:hpo ids='HP_0001511'>intrauterine growth retardation</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and <z:e sem="disease" ids="C0015930" disease_type="Disease or Syndrome" abbrv="">fetal distress</z:e> necessitating urgent delivery of a live infant </plain></SENT>
<SENT sid="2" pm="."><plain>There was a prior history of unexplained jugular <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Prophylaxis against <z:mp ids='MP_0005048'>thrombosis</z:mp> was commenced immediately postoperatively and no <z:e sem="disease" ids="C0852263" disease_type="Disease or Syndrome" abbrv="">postpartum complications</z:e> occurred </plain></SENT>
<SENT sid="4" pm="."><plain>Recent evidence supports the use of antepartum prophylaxis with low dose <z:chebi fb="5" ids="28304">heparin</z:chebi> in patients with APS </plain></SENT>
<SENT sid="5" pm="."><plain>The role of low dose aspirin, either alone or in combination with <z:chebi fb="5" ids="28304">heparin</z:chebi>, is yet to be determined </plain></SENT>
<SENT sid="6" pm="."><plain>Human immunoglobulin may be useful in selected cases </plain></SENT>
<SENT sid="7" pm="."><plain>Early diagnosis is a key factor in their management </plain></SENT>
</text></document>